NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Really? A 95% probability of approval DCVax-L by MHRA in the UK, according to Larry Smith (Smith on Stocks) and there's nothing to talk about???

So long time penny stock pumper/blogger once more tosses out nonsense pumping his favorite stock. And that is news?

In his first pump piece from 2012 he made some whopping projections after TLD would be released in 2013/4. On good results $144/share (his $9 was pre 16-1 RS). And if the results were "meh" then $16/share.

What is far worse are his financial numbers. The biggest fail was the cash position after the sale of Sawston. He said that provided them enough cash to get to mid 2020. In reality it didn't even last through the summer. He also said the cash meant they would not need a raise before approval decision in 2020.

But 95%, sure pal.

We are looking at a randomized P3 where the endpoints between the trial as randomized were a disaster. The primary PFS failed and the secondary OS almost certain failed badly. That NWBO fails to disclose it (despite still being a formal endpoint of the trial) should tell one all they need to know on that.

Others have played the game of saying that despite the failure of the randomized trial the drug worked. Sometime it can even be true. Just others do not bother conning investors into thinking that it stands a chance of being approved based on a single failed trial. Well, I guess some do. looks like CVM is following the same path as NWBO.